Accordingly, the direct involvement of Notch signaling has recently been demonstrated in obesity and type 2 diabetes [44]: through transcriptional binding partners FoxO1 and Rbpj, Notch activation enhances pathologic glucose output and fatty liver in obese, in combination with a reduced Akt activation by insulin. Here, AKT1 is linked to obesity due to melanocortin 4 receptor deficiency.